US Edition
News from Drug Delivery Business
Top Drug Delivery Business News
Jim CramerLive Updates
Live Coverage
Updates appear automatically as they are published.
Abbott Continues to Sink
12:03 pm by Eric Bleeker
As of midday, shares of Abbott continue to trend lower. The company’s shares are down about 8%. While Abbott’s shares have plummeted today, they are still up about 7% year-to-date.
Growth Rates
10:50 am by Eric Bleeker
Here’s a look at Abbott’s growth rates:
Metric Q2 25 Q2 2024 YoY Change
revenue $11.14B $10.…See the Story
Abbott Labs (NYSE: ABT) Sinks 6% After Releasing Q2 Earnings
75% Center coverage: 4 sources
Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market - Trinity Biotech (NASDAQ:TRIB)
100% Center coverage: 2 sources
Piombino Dese · Piombino DeseStevanato Group today announced that it secured $235.5 million (€200 million) in financing to support ongoing capital expenditure projects. The Piombino Dese, Italy-based drug delivery device developer plans to use funds to support projects in Cisterna di Latina (Italy) and Fishers, Indiana. It picked up the funds through agreements with BNL BNP Paribas, Cassa Depositi e Prestiti (CDP) and Banco BPM. Stevanato Group says the financings bolster i…See the Story
Drug Delivery Tech Developer Stevanato Group Brings in $235.5M
Coverage: 2 sources
